Thus, inhibiting LUCAT1 promotes ferroptosis through the miR-34a-5p-mediated GCH1 downregulation, suggesting a potential treatment strategy for lung cancer (Tai et al., 2024). Here, LUCAT1 is linked to lung carcinoma.